Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Created on 14 Aug 2026

Authors

Jin Yi Goh, Lai Gwen Chan, Francisco Cardoso, Louis C S Tan

Published in

Movement disorders clinical practice. Aug 13, 2026. Epub Aug 13, 2026.

Abstract

Impulse control-related behavioral disorders refer to a group of compulsive behaviors seen in patients with Parkinson's disease (PD), comprising impulse control disorders (ICD), dopamine dysregulation syndrome (DDS), and punding. Over the years, numerous studies have been published on their prevalence, risk factors, neuroimaging, genetics, and management. More evidence now suggests that each disorder involves a distinct neurobiological mechanism. Although our understanding has improved, early recognition and appropriate treatment remain a significant challenge for clinicians, patients, and caregivers alike.
We aimed to summarize the definitions, underlying neurobiological mechanisms, validated assessment tools (for screening and rating), management strategies, and future directions for each of these impulse-control and related behavioral disorders (ICBD).
We performed a scoping review of PubMed, Embase, and psycINFO.
A database search identified 540 articles, of which 110 were selected for full-text review. We classified the articles into 6 themes as follows: prevalence, risk factors, genetics, behavioral studies, neuroimaging, and treatment options. Based on the selected articles, we discussed the clinical phenotypes, pathophysiology, and treatment approaches for ICD, DDS, and punding. Identified knowledge gaps include the limited understanding of the pathophysiology of punding and validated rating scales for clinical use in assessing punding and DDS. Future research directions include investigating the role of selective serotonin 5-hydroxytryptamine 2A receptor inverse agonists, selective D1/D5 partial dopamine agonists, and transcranial magnetic stimulation in the treatment of ICBDs in PD.
Early recognition and distinguishing among the different ICBDs are essential to enable early intervention, specific tailored management, and monitoring of these disorders and their respective treatment effects.

PMID:
42596651
Bibliographic data and abstract were imported from PubMed on 14 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement